data_1heh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1heh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.486 -0.561 . . . . 7.2199999999999998 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 150.89 36.52 0.03 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.713 -1.355 . . . . 4.9400000000000004 109.713 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 559' ' ' SER . . . . . 0.511 ' CB ' HG21 ' C' ' 643' ' ' THR . 0.8 OUTLIER -59.0 158.76 8.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 3.6499999999999999 109.229 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 560' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 0.0 OUTLIER -85.24 157.83 20.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 2.3500000000000001 109.296 179.971 119.351 -107.896 77.949 104.745 2.024 103.94 -145.559 -93.155 3 3 . 1 . 001 nuclear orig full ' C' C ' 561' ' ' SER . . . . . 0.524 ' CB ' ' HB2' ' C' ' 581' ' ' SER . 16.0 m -98.22 132.52 43.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 2.04 109.195 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 562' ' ' VAL . . . . . 0.609 ' CG1' ' SG ' ' C' ' 560' ' ' CYS . 2.7 m -146.08 173.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 2.0499999999999998 110.15 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 563' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 23.6 m -160.14 138.27 10.07 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.711 -0.848 . . . . 1.72 108.711 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -113.68 129.63 56.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.08 . . . . 1.48 109.95 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 565' ' ' VAL . . . . . 0.606 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 2.0 t -128.27 157.86 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.802 . . . . 1.3 109.036 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 566' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' C' ' 567' ' ' GLY . 0.3 OUTLIER -75.9 60.14 1.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 4.0599999999999996 108.861 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 567' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -46.09 175.9 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.697 -1.361 . . . . 0.66000000000000003 109.697 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 568' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 19.5 mt-10 -40.22 161.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.141 . . . . 1.97 109.805 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -160.22 -172.8 3.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 2.4900000000000002 109.509 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 570' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 14.9 m-90 -151.1 -167.77 2.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 1.8899999999999999 109.369 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -90.72 -45.65 8.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 2.5800000000000001 109.511 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 572' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' C' ' 630' ' ' LYS . 1.2 m-20 -82.57 -25.37 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 2.1600000000000001 109.469 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 573' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' C' ' 570' ' ' TRP . 0.0 OUTLIER -144.6 155.59 43.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 2.5299999999999998 109.44 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 574' ' ' PHE . . . . . 0.63 ' CZ ' ' CB ' ' C' ' 628' ' ' PHE . 51.2 p90 -124.23 158.64 31.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 2.4100000000000001 109.383 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 575' ' ' ASN . . . . . 0.592 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.6 t-20 -125.89 173.3 9.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.75 109.481 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 576' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 2.2 t -149.34 156.09 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.358 -0.839 . . . . 1.1499999999999999 109.371 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 47.5 m -123.29 94.25 4.2 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.071 -0.714 . . . . 1.1599999999999999 109.071 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 578' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' C' ' 563' ' ' SER . 78.3 m-85 -79.88 146.13 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 2.25 109.69 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 67.6 m -123.46 141.56 51.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.905 . . . . 1.1100000000000001 109.573 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 580' ' ' VAL . . . . . 0.724 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 20.9 t -118.12 154.72 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.829 . . . . 1.4099999999999999 109.391 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 581' ' ' SER . . . . . 0.524 ' HB2' ' CB ' ' C' ' 561' ' ' SER . 0.3 OUTLIER -101.64 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.124 -0.985 . . . . 2.1099999999999999 109.492 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . -134.16 45.02 1.14 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.403 -1.479 . . . . 2.4399999999999999 109.403 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 583' ' ' SER . . . . . 0.484 ' OG ' HG12 ' C' ' 580' ' ' VAL . 40.8 m -85.43 46.92 1.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -1.168 . . . . 4.4900000000000002 109.556 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 584' ' ' SER . . . . . 0.484 ' C ' ' O ' ' C' ' 583' ' ' SER . 0.5 OUTLIER -40.33 -36.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 2.6000000000000001 109.083 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.45 93.4 6.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 2.7599999999999998 108.981 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 586' ' ' TRP . . . . . 0.724 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 29.5 m95 -69.58 124.83 24.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 2.0499999999999998 110.519 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 587' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' C' ' 586' ' ' TRP . 23.6 t -160.03 32.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.674 -0.862 . . . . 2.1400000000000001 108.674 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 588' ' ' VAL . . . . . 0.818 HG21 ' O ' ' C' ' 640' ' ' THR . 2.3 p -79.6 162.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 1.9299999999999999 109.879 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 589' ' ' THR . . . . . 0.634 ' H ' HG21 ' C' ' 588' ' ' VAL . 0.0 OUTLIER -127.02 107.24 9.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 1.6699999999999999 108.888 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 590' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' C' ' 639' ' ' ALA . 0.7 OUTLIER -79.5 139.71 37.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 1.6499999999999999 109.549 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -117.62 106.48 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.81999999999999995 109.682 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 592' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' C' ' 596' ' ' GLN . 69.4 mt -65.02 -167.93 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.239 -1.153 . . . . 1.97 109.714 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 593' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' C' ' 594' ' ' GLY . 17.1 m-80 -121.7 59.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.253 -0.904 . . . . 2.3799999999999999 109.47 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 594' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' C' ' 593' ' ' ASN . . . 46.44 95.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.572 -1.411 . . . . 3.02 109.572 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 595' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' C' ' 596' ' ' GLN . . . 115.81 -63.35 0.34 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.525 -1.43 . . . . 1.6499999999999999 109.525 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 596' ' ' GLN . . . . . 0.497 ' O ' ' CD1' ' C' ' 592' ' ' LEU . 21.2 mt-30 -44.03 114.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 1.8799999999999999 109.403 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.16 160.57 18.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 1.6000000000000001 109.535 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.3 136.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 1.1799999999999999 109.565 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 599' ' ' GLN . . . . . 0.47 ' HB3' ' HB ' ' C' ' 627' ' ' THR . 2.3 tt0 -107.42 -43.24 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 2.6699999999999999 109.426 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.52 159.7 19.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 1.4099999999999999 109.542 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 601' ' ' SER . . . . . 0.498 ' OG ' ' CD2' ' C' ' 606' ' ' LEU . 1.6 p -147.96 170.72 17.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 1.78 109.465 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 602' ' ' TRP . . . . . 0.528 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 40.7 p90 -159.48 153.7 23.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 1.49 109.616 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 603' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' C' ' 604' ' ' ALA . 0.0 OUTLIER 77.16 25.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 2.2000000000000002 109.644 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 604' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 162.94 168.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 1.45 109.492 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 605' ' ' ALA . . . . . 0.443 ' C ' HD21 ' C' ' 606' ' ' LEU . . . -114.12 152.2 31.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 2.1000000000000001 109.431 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 606' ' ' LEU . . . . . 0.504 ' N ' HD21 ' C' ' 606' ' ' LEU . 0.1 OUTLIER -131.16 151.61 51.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 2.8399999999999999 109.498 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 607' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' C' ' 613' ' ' VAL . 9.1 m -114.79 122.88 47.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 1.47 109.331 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 608' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' C' ' 613' ' ' VAL . . . 102.15 176.03 27.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.477 -1.449 . . . . 1.75 109.477 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 609' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' C' ' 610' ' ' SER . 0.7 OUTLIER -156.93 22.83 0.32 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 1.8799999999999999 109.625 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 610' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.3 OUTLIER 169.89 108.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 1.8400000000000001 109.516 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 120.86 -91.03 0.47 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.85999999999999999 109.504 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -134.19 109.71 9.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -1.171 . . . . 1.47 109.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 613' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' C' ' 607' ' ' THR . 2.1 t -110.04 162.31 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.276 -0.89 . . . . 1.5 109.324 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 614' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 76.6 m -135.26 147.32 49.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 1.3500000000000001 109.51 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 615' ' ' ALA . . . . . 0.637 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -82.17 153.74 25.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.201 -0.937 . . . . 1.4399999999999999 109.563 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.05 151.85 68.78 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 3.7799999999999998 109.302 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 153.07 30.06 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.674 2.25 . . . . 1.6100000000000001 110.426 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 618' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' C' ' 618' ' ' ASN . 47.3 p-10 -152.25 20.98 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 3.3199999999999998 109.431 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 619' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 140.31 -51.1 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.542 -1.423 . . . . 1.8700000000000001 109.542 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 620' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.5 OUTLIER 164.17 113.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -1.158 . . . . 2.9500000000000002 109.4 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -172.51 132.13 2.31 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.5 -1.44 . . . . 1.3200000000000001 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 622' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 10.4 m120 -118.91 -14.98 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 1.1899999999999999 109.458 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 623' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 0.6 OUTLIER -116.52 115.96 26.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 1.4399999999999999 109.161 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 624' ' ' PHE . . . . . 0.525 ' CB ' ' HB1' ' C' ' 604' ' ' ALA . 27.1 p90 -132.08 143.37 49.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 2.3199999999999998 109.718 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 625' ' ' GLY . . . . . 0.4 ' O ' HG21 ' C' ' 626' ' ' VAL . . . -112.94 153.62 17.42 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.321 -1.512 . . . . 0.47999999999999998 109.321 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 626' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' C' ' 601' ' ' SER . 59.5 t -145.4 151.6 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -1.175 . . . . 1.23 109.606 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 627' ' ' THR . . . . . 0.524 ' O ' ' CG ' ' C' ' 628' ' ' PHE . 6.8 m -89.54 171.11 9.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 1.1599999999999999 109.324 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 628' ' ' PHE . . . . . 0.63 ' CB ' ' CZ ' ' C' ' 574' ' ' PHE . 82.5 m-85 -159.23 111.95 2.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 2.2400000000000002 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 629' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 42.0 m-85 -69.93 141.17 53.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 2.2999999999999998 109.292 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 630' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' C' ' 573' ' ' ARG . 0.0 OUTLIER -115.84 -61.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 4.5 109.448 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 631' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' C' ' 630' ' ' LYS . 14.3 m-20 43.06 29.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -0.897 . . . . 3.4500000000000002 109.541 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 123.37 28.93 1.26 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.848 -1.301 . . . . 3.6400000000000001 109.848 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 633' ' ' SER . . . . . 0.474 ' HB3' ' HA ' ' C' ' 630' ' ' LYS . 60.1 p -88.42 -148.57 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.122 -1.222 . . . . 3.4500000000000002 109.319 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 634' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' C' ' 633' ' ' SER . 31.9 m -171.5 -112.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 3.77 109.65 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 635' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' C' ' 634' ' ' SER . . . -43.42 134.46 3.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 1.8999999999999999 109.77 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 636' ' ' THR . . . . . 0.586 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 0.1 OUTLIER -73.27 165.75 50.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.317 -0.864 . . . . 2.1400000000000001 109.435 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 637' ' ' PRO . . . . . 0.586 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 35.7 Cg_endo -78.64 171.9 15.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.729 2.286 . . . . 1.1799999999999999 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -155.68 156.34 26.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.689 -1.364 . . . . 1.23 109.689 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 639' ' ' ALA . . . . . 0.416 ' HA ' ' HG ' ' C' ' 590' ' ' LEU . . . -100.78 135.05 42.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 1.4099999999999999 109.404 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 640' ' ' THR . . . . . 0.818 ' O ' HG21 ' C' ' 588' ' ' VAL . 0.4 OUTLIER -94.39 148.66 22.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.955 0.884 . . . . 1.4299999999999999 110.789 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 641' ' ' CYS . . . . . 0.576 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 1.4 m -160.38 69.62 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 2.04 109.479 178.981 -93.155 -145.559 77.949 103.94 2.024 104.745 -107.896 119.351 2 2 . 1 . 001 nuclear orig full ' C' C ' 642' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' C' ' 559' ' ' SER . . . -123.91 169.48 11.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.875 . . . . 4.1299999999999999 109.568 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 643' ' ' THR . . . . . 0.511 HG21 ' CB ' ' C' ' 559' ' ' SER . 43.1 p -116.63 105.42 12.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 4.79 109.451 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.021 -1.433 . . . . 7.4000000000000004 109.535 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.486 -0.561 . . . . 6.91 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 150.89 36.52 0.03 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.713 -1.355 . . . . 4.71 109.713 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 559' ' ' SER . . . . . 0.702 ' OG ' HG23 ' C' ' 643' ' ' THR . 0.8 OUTLIER -59.0 158.76 8.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 3.49 109.229 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 560' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 0.0 OUTLIER -85.24 157.83 20.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 2.35 109.296 179.971 119.351 -107.896 77.949 104.745 2.024 103.94 -145.559 -93.155 3 3 . 1 . 001 nuclear build full ' C' C ' 561' ' ' SER . . . . . 0.55 ' CB ' ' HB2' ' C' ' 581' ' ' SER . 16.0 m -98.22 132.52 43.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 1.72 109.195 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 562' ' ' VAL . . . . . 0.62 HG11 ' SG ' ' C' ' 641' ' ' CYS . 2.7 m -146.08 173.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 1.41 110.15 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 563' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 23.6 m -160.14 138.27 10.07 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.711 -0.848 . . . . 1.44 108.711 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -113.68 129.63 56.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.08 . . . . 0.83 109.95 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 565' ' ' VAL . . . . . 0.722 ' O ' HG13 ' C' ' 576' ' ' VAL . 2.0 t -128.27 157.86 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.802 . . . . 0.76 109.036 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 566' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' C' ' 567' ' ' GLY . 0.3 OUTLIER -75.9 60.14 1.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 3.46 108.861 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 567' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -46.09 175.9 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.697 -1.361 . . . . 0.66 109.697 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 568' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 19.5 mt-10 -40.22 161.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.141 . . . . 1.97 109.805 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -160.22 -172.8 3.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 2.49 109.509 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 570' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 14.9 m-90 -151.1 -167.77 2.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 1.89 109.369 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -90.72 -45.65 8.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 1.98 109.511 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 572' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' C' ' 630' ' ' LYS . 1.2 m-20 -82.57 -25.37 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 2.16 109.469 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 573' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -144.6 155.59 43.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 2.01 109.44 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 574' ' ' PHE . . . . . 0.63 ' CZ ' ' CB ' ' C' ' 628' ' ' PHE . 51.2 p90 -124.23 158.64 31.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 1.52 109.383 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 575' ' ' ASN . . . . . 0.592 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.6 t-20 -125.89 173.3 9.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.25 109.481 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 576' ' ' VAL . . . . . 0.722 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.2 t -149.34 156.09 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.358 -0.839 . . . . 0.41 109.371 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 47.5 m -123.29 94.25 4.2 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.071 -0.714 . . . . 0.47 109.071 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 578' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' C' ' 563' ' ' SER . 78.3 m-85 -79.88 146.13 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 1.36 109.69 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 67.6 m -123.46 141.56 51.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.905 . . . . 0.77 109.573 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 580' ' ' VAL . . . . . 1.078 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 20.9 t -118.12 154.72 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.829 . . . . 0.84 109.391 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 581' ' ' SER . . . . . 0.55 ' HB2' ' CB ' ' C' ' 561' ' ' SER . 0.3 OUTLIER -101.64 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.124 -0.985 . . . . 1.8 109.492 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . -134.16 45.02 1.14 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.403 -1.479 . . . . 2.15 109.403 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 583' ' ' SER . . . . . 0.639 ' HB2' HG11 ' C' ' 580' ' ' VAL . 40.8 m -85.43 46.92 1.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -1.168 . . . . 4.03 109.556 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 584' ' ' SER . . . . . 0.484 ' C ' ' O ' ' C' ' 583' ' ' SER . 0.5 OUTLIER -40.33 -36.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 2.22 109.083 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.45 93.4 6.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 2.37 108.981 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 586' ' ' TRP . . . . . 1.078 ' CZ2' HG21 ' C' ' 580' ' ' VAL . 29.5 m95 -69.58 124.83 24.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 1.55 110.519 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 587' ' ' VAL . . . . . 0.579 HG12 ' O ' ' C' ' 587' ' ' VAL . 23.6 t -160.03 32.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.674 -0.862 . . . . 1.58 108.674 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 588' ' ' VAL . . . . . 1.107 HG23 ' O ' ' C' ' 640' ' ' THR . 2.3 p -79.6 162.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 1.28 109.879 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 589' ' ' THR . . . . . 0.624 ' N ' HG22 ' C' ' 588' ' ' VAL . 0.0 OUTLIER -127.02 107.24 9.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 1.03 108.888 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 590' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' C' ' 639' ' ' ALA . 0.7 OUTLIER -79.5 139.71 37.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 1.09 109.549 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -117.62 106.48 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.82 109.682 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 592' ' ' LEU . . . . . 0.998 HD13 ' O ' ' C' ' 596' ' ' GLN . 69.4 mt -65.02 -167.93 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.239 -1.153 . . . . 1.33 109.714 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 593' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' C' ' 594' ' ' GLY . 5.1 m120 -121.7 59.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.253 -0.904 . . . . 2.38 109.47 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 594' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' C' ' 593' ' ' ASN . . . 46.44 95.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.572 -1.411 . . . . 2.38 109.572 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 595' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' C' ' 596' ' ' GLN . . . 115.81 -63.35 0.34 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.525 -1.43 . . . . 1.07 109.525 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 596' ' ' GLN . . . . . 0.998 ' O ' HD13 ' C' ' 592' ' ' LEU . 21.2 mt-30 -44.03 114.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 1.55 109.403 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.16 160.57 18.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 1.11 109.535 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 598' ' ' VAL . . . . . 0.468 HG13 ' CG1' ' C' ' 626' ' ' VAL . 99.1 t -84.3 136.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.59 109.565 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 599' ' ' GLN . . . . . 0.495 ' HB3' ' HB ' ' C' ' 627' ' ' THR . 2.3 tt0 -107.42 -43.24 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 2.3 109.426 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.52 159.7 19.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 1.09 109.542 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 601' ' ' SER . . . . . 0.882 ' OG ' HD21 ' C' ' 606' ' ' LEU . 1.6 p -147.96 170.72 17.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 1.28 109.465 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 602' ' ' TRP . . . . . 0.528 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 40.7 p90 -159.48 153.7 23.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 1.27 109.616 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 603' ' ' ASN . . . . . 0.705 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 1.3 t-20 77.16 25.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 1.51 109.644 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 604' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 162.94 168.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.97 109.492 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 605' ' ' ALA . . . . . 0.532 ' C ' HD23 ' C' ' 606' ' ' LEU . . . -114.12 152.2 31.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 1.58 109.431 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 606' ' ' LEU . . . . . 0.882 HD21 ' OG ' ' C' ' 601' ' ' SER . 0.1 OUTLIER -131.16 151.61 51.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 2.33 109.498 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 607' ' ' THR . . . . . 0.928 ' O ' HG22 ' C' ' 613' ' ' VAL . 9.1 m -114.79 122.88 47.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.99 109.331 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 608' ' ' GLY . . . . . 0.431 ' CA ' HG22 ' C' ' 613' ' ' VAL . . . 102.15 176.03 27.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.477 -1.449 . . . . 1.75 109.477 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 609' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' C' ' 610' ' ' SER . 0.7 OUTLIER -156.93 22.83 0.32 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 1.51 109.625 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 610' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.3 OUTLIER 169.89 108.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 1.42 109.516 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 120.86 -91.03 0.47 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.82 109.504 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -134.19 109.71 9.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -1.171 . . . . 0.83 109.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 613' ' ' VAL . . . . . 0.928 HG22 ' O ' ' C' ' 607' ' ' THR . 2.1 t -110.04 162.31 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.276 -0.89 . . . . 0.78 109.324 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 614' ' ' THR . . . . . 0.66 HG23 ' O ' ' C' ' 588' ' ' VAL . 76.6 m -135.26 147.32 49.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.75 109.51 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 615' ' ' ALA . . . . . 0.797 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -82.17 153.74 25.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.201 -0.937 . . . . 0.76 109.563 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.05 151.85 68.78 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 3.18 109.302 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 153.07 30.06 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.674 2.25 . . . . 1.3 110.426 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 618' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' C' ' 618' ' ' ASN . 47.3 p-10 -152.25 20.98 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 2.66 109.431 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 619' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 140.31 -51.1 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.542 -1.423 . . . . 1.87 109.542 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 620' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.5 OUTLIER 164.17 113.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -1.158 . . . . 2.61 109.4 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -172.51 132.13 2.31 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.5 -1.44 . . . . 1.09 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 622' ' ' ASN . . . . . 0.513 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 10.4 m120 -118.91 -14.98 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 1.1 109.458 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 623' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 0.6 OUTLIER -116.52 115.96 26.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 1.24 109.161 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 624' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' C' ' 624' ' ' PHE . 27.1 p90 -132.08 143.37 49.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 1.46 109.718 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -112.94 153.62 17.42 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.321 -1.512 . . . . 0.42 109.321 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 626' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' C' ' 601' ' ' SER . 59.5 t -145.4 151.6 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -1.175 . . . . 0.57 109.606 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 627' ' ' THR . . . . . 0.539 HG22 ' H ' ' C' ' 628' ' ' PHE . 6.8 m -89.54 171.11 9.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.72 109.324 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 628' ' ' PHE . . . . . 0.63 ' CB ' ' CZ ' ' C' ' 574' ' ' PHE . 82.5 m-85 -159.23 111.95 2.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.32 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 629' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 42.0 m-85 -69.93 141.17 53.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 1.41 109.292 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 630' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' C' ' 573' ' ' ARG . 0.0 OUTLIER -115.84 -61.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 4.13 109.448 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 631' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' C' ' 630' ' ' LYS . 14.3 m-20 43.06 29.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -0.897 . . . . 3.45 109.541 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 123.37 28.93 1.26 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.848 -1.301 . . . . 3.03 109.848 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 633' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' C' ' 630' ' ' LYS . 60.1 p -88.42 -148.57 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.122 -1.222 . . . . 3.04 109.319 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 634' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' C' ' 633' ' ' SER . 31.9 m -171.5 -112.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 3.29 109.65 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 635' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' C' ' 634' ' ' SER . . . -43.42 134.46 3.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 1.35 109.77 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 636' ' ' THR . . . . . 0.942 HG22 ' HD2' ' C' ' 637' ' ' PRO . 0.1 OUTLIER -73.27 165.75 50.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.317 -0.864 . . . . 1.52 109.435 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 637' ' ' PRO . . . . . 0.942 ' HD2' HG22 ' C' ' 636' ' ' THR . 35.7 Cg_endo -78.64 171.9 15.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.729 2.286 . . . . 1.18 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -155.68 156.34 26.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.689 -1.364 . . . . 1.07 109.689 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 639' ' ' ALA . . . . . 0.87 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -100.78 135.05 42.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 0.86 109.404 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 640' ' ' THR . . . . . 1.107 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.4 OUTLIER -94.39 148.66 22.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.955 0.884 . . . . 0.78 110.789 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 641' ' ' CYS . . . . . 0.62 ' SG ' HG11 ' C' ' 562' ' ' VAL . 1.4 m -160.38 69.62 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 2.04 109.479 178.981 -93.155 -145.559 77.949 103.94 2.024 104.745 -107.896 119.351 2 2 . 1 . 001 nuclear build full ' C' C ' 642' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' C' ' 559' ' ' SER . . . -123.91 169.48 11.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.875 . . . . 3.67 109.568 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 643' ' ' THR . . . . . 0.702 HG23 ' OG ' ' C' ' 559' ' ' SER . 43.1 p -116.63 105.42 12.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 4.79 109.451 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.021 -1.433 . . . . 7.4 109.535 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.486 -0.561 . . . . 6.9100000000000001 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 150.89 36.52 0.03 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.713 -1.355 . . . . 4.71 109.713 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 559' ' ' SER . . . . . 0.702 ' OG ' HG23 ' C' ' 643' ' ' THR . 0.8 OUTLIER -59.0 158.76 8.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 3.4900000000000002 109.229 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 560' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 0.0 OUTLIER -85.24 157.83 20.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 2.3500000000000001 109.296 179.971 119.351 -107.896 77.949 104.745 2.024 103.94 -145.559 -93.155 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 561' ' ' SER . . . . . 0.55 ' CB ' ' HB2' ' C' ' 581' ' ' SER . 16.0 m -98.22 132.52 43.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 1.72 109.195 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 562' ' ' VAL . . . . . 0.62 HG11 ' SG ' ' C' ' 641' ' ' CYS . 2.7 m -146.08 173.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 1.4099999999999999 110.15 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 563' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 23.6 m -160.14 138.27 10.07 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.711 -0.848 . . . . 1.4399999999999999 108.711 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -113.68 129.63 56.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.08 . . . . 0.82999999999999996 109.95 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 565' ' ' VAL . . . . . 0.722 ' O ' HG13 ' C' ' 576' ' ' VAL . 2.0 t -128.27 157.86 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.802 . . . . 0.76000000000000001 109.036 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 566' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' C' ' 567' ' ' GLY . 0.3 OUTLIER -75.9 60.14 1.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 3.46 108.861 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 567' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -46.09 175.9 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.697 -1.361 . . . . 0.66000000000000003 109.697 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 568' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 19.5 mt-10 -40.22 161.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.141 . . . . 1.97 109.805 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -160.22 -172.8 3.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 2.4900000000000002 109.509 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 570' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 14.9 m-90 -151.1 -167.77 2.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 1.8899999999999999 109.369 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -90.72 -45.65 8.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 1.98 109.511 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 572' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' C' ' 630' ' ' LYS . 1.2 m-20 -82.57 -25.37 33.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 2.1600000000000001 109.469 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 573' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -144.6 155.59 43.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 2.0099999999999998 109.44 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 574' ' ' PHE . . . . . 0.63 ' CZ ' ' CB ' ' C' ' 628' ' ' PHE . 51.2 p90 -124.23 158.64 31.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 1.52 109.383 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 575' ' ' ASN . . . . . 0.592 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.6 t-20 -125.89 173.3 9.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.25 109.481 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 576' ' ' VAL . . . . . 0.722 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.2 t -149.34 156.09 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.358 -0.839 . . . . 0.40999999999999998 109.371 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 47.5 m -123.29 94.25 4.2 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.071 -0.714 . . . . 0.46999999999999997 109.071 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 578' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' C' ' 563' ' ' SER . 78.3 m-85 -79.88 146.13 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 1.3600000000000001 109.69 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 67.6 m -123.46 141.56 51.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.905 . . . . 0.77000000000000002 109.573 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 580' ' ' VAL . . . . . 1.078 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 20.9 t -118.12 154.72 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.829 . . . . 0.83999999999999997 109.391 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 581' ' ' SER . . . . . 0.55 ' HB2' ' CB ' ' C' ' 561' ' ' SER . 0.3 OUTLIER -101.64 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.124 -0.985 . . . . 1.8 109.492 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . -134.16 45.02 1.14 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.403 -1.479 . . . . 2.1499999999999999 109.403 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 583' ' ' SER . . . . . 0.639 ' HB2' HG11 ' C' ' 580' ' ' VAL . 40.8 m -85.43 46.92 1.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -1.168 . . . . 4.0300000000000002 109.556 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 584' ' ' SER . . . . . 0.484 ' C ' ' O ' ' C' ' 583' ' ' SER . 0.5 OUTLIER -40.33 -36.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 2.2200000000000002 109.083 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.45 93.4 6.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 2.3700000000000001 108.981 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 586' ' ' TRP . . . . . 1.078 ' CZ2' HG21 ' C' ' 580' ' ' VAL . 29.5 m95 -69.58 124.83 24.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 1.55 110.519 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 587' ' ' VAL . . . . . 0.579 ' O ' HG12 ' C' ' 587' ' ' VAL . 23.6 t -160.03 32.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.674 -0.862 . . . . 1.5800000000000001 108.674 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 588' ' ' VAL . . . . . 1.107 HG23 ' O ' ' C' ' 640' ' ' THR . 2.3 p -79.6 162.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 1.28 109.879 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 589' ' ' THR . . . . . 0.624 ' N ' HG22 ' C' ' 588' ' ' VAL . 0.0 OUTLIER -127.02 107.24 9.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 1.03 108.888 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 590' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' C' ' 639' ' ' ALA . 0.7 OUTLIER -79.5 139.71 37.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 1.0900000000000001 109.549 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -117.62 106.48 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.81999999999999995 109.682 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 592' ' ' LEU . . . . . 0.998 HD13 ' O ' ' C' ' 596' ' ' GLN . 69.4 mt -65.02 -167.93 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.239 -1.153 . . . . 1.3300000000000001 109.714 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 593' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' C' ' 594' ' ' GLY . 17.1 m-80 -121.7 59.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.253 -0.904 . . . . 2.3799999999999999 109.47 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 594' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' C' ' 593' ' ' ASN . . . 46.44 95.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.572 -1.411 . . . . 2.3799999999999999 109.572 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 595' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' C' ' 596' ' ' GLN . . . 115.81 -63.35 0.34 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.525 -1.43 . . . . 1.0700000000000001 109.525 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 596' ' ' GLN . . . . . 0.998 ' O ' HD13 ' C' ' 592' ' ' LEU . 21.2 mt-30 -44.03 114.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 1.55 109.403 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.16 160.57 18.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 1.1100000000000001 109.535 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 598' ' ' VAL . . . . . 0.468 HG13 ' CG1' ' C' ' 626' ' ' VAL . 99.1 t -84.3 136.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.58999999999999997 109.565 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 599' ' ' GLN . . . . . 0.495 ' HB3' ' HB ' ' C' ' 627' ' ' THR . 2.3 tt0 -107.42 -43.24 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 2.2999999999999998 109.426 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.52 159.7 19.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 1.0900000000000001 109.542 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 601' ' ' SER . . . . . 0.882 ' OG ' HD21 ' C' ' 606' ' ' LEU . 1.6 p -147.96 170.72 17.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 1.28 109.465 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 602' ' ' TRP . . . . . 0.528 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 40.7 p90 -159.48 153.7 23.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 1.27 109.616 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 603' ' ' ASN . . . . . 0.705 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.0 OUTLIER 77.16 25.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 1.51 109.644 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 604' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 162.94 168.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.96999999999999997 109.492 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 605' ' ' ALA . . . . . 0.532 ' C ' HD23 ' C' ' 606' ' ' LEU . . . -114.12 152.2 31.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 1.5800000000000001 109.431 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 606' ' ' LEU . . . . . 0.882 HD21 ' OG ' ' C' ' 601' ' ' SER . 0.1 OUTLIER -131.16 151.61 51.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 2.3300000000000001 109.498 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 607' ' ' THR . . . . . 0.928 ' O ' HG22 ' C' ' 613' ' ' VAL . 9.1 m -114.79 122.88 47.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.98999999999999999 109.331 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 608' ' ' GLY . . . . . 0.431 ' CA ' HG22 ' C' ' 613' ' ' VAL . . . 102.15 176.03 27.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.477 -1.449 . . . . 1.75 109.477 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 609' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' C' ' 610' ' ' SER . 0.7 OUTLIER -156.93 22.83 0.32 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 1.51 109.625 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 610' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.3 OUTLIER 169.89 108.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 1.4199999999999999 109.516 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 120.86 -91.03 0.47 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.81999999999999995 109.504 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -134.19 109.71 9.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -1.171 . . . . 0.82999999999999996 109.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 613' ' ' VAL . . . . . 0.928 HG22 ' O ' ' C' ' 607' ' ' THR . 2.1 t -110.04 162.31 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.276 -0.89 . . . . 0.78000000000000003 109.324 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 614' ' ' THR . . . . . 0.66 HG23 ' O ' ' C' ' 588' ' ' VAL . 76.6 m -135.26 147.32 49.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.75 109.51 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 615' ' ' ALA . . . . . 0.797 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -82.17 153.74 25.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.201 -0.937 . . . . 0.76000000000000001 109.563 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.05 151.85 68.78 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 3.1800000000000002 109.302 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.6 153.07 30.06 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.674 2.25 . . . . 1.3 110.426 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 618' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' C' ' 618' ' ' ASN . 47.3 p-10 -152.25 20.98 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 2.6600000000000001 109.431 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 619' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 140.31 -51.1 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.542 -1.423 . . . . 1.8700000000000001 109.542 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 620' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.5 OUTLIER 164.17 113.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -1.158 . . . . 2.6099999999999999 109.4 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -172.51 132.13 2.31 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.5 -1.44 . . . . 1.0900000000000001 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 622' ' ' ASN . . . . . 0.513 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 10.4 m120 -118.91 -14.98 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 1.1000000000000001 109.458 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 623' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 0.6 OUTLIER -116.52 115.96 26.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 1.24 109.161 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 624' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' C' ' 624' ' ' PHE . 27.1 p90 -132.08 143.37 49.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 1.46 109.718 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -112.94 153.62 17.42 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.321 -1.512 . . . . 0.41999999999999998 109.321 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 626' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' C' ' 601' ' ' SER . 59.5 t -145.4 151.6 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -1.175 . . . . 0.56999999999999995 109.606 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 627' ' ' THR . . . . . 0.539 HG22 ' H ' ' C' ' 628' ' ' PHE . 6.8 m -89.54 171.11 9.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.71999999999999997 109.324 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 628' ' ' PHE . . . . . 0.63 ' CB ' ' CZ ' ' C' ' 574' ' ' PHE . 82.5 m-85 -159.23 111.95 2.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.3200000000000001 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 629' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 42.0 m-85 -69.93 141.17 53.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 1.4099999999999999 109.292 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 630' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' C' ' 573' ' ' ARG . 0.0 OUTLIER -115.84 -61.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 4.1299999999999999 109.448 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 631' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' C' ' 630' ' ' LYS . 14.3 m-20 43.06 29.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -0.897 . . . . 3.4500000000000002 109.541 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 123.37 28.93 1.26 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.848 -1.301 . . . . 3.0299999999999998 109.848 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 633' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' C' ' 630' ' ' LYS . 60.1 p -88.42 -148.57 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.122 -1.222 . . . . 3.04 109.319 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 634' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' C' ' 633' ' ' SER . 31.9 m -171.5 -112.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 3.29 109.65 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 635' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' C' ' 634' ' ' SER . . . -43.42 134.46 3.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 1.3500000000000001 109.77 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 636' ' ' THR . . . . . 0.942 HG22 ' HD2' ' C' ' 637' ' ' PRO . 0.1 OUTLIER -73.27 165.75 50.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.317 -0.864 . . . . 1.52 109.435 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 637' ' ' PRO . . . . . 0.942 ' HD2' HG22 ' C' ' 636' ' ' THR . 35.7 Cg_endo -78.64 171.9 15.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.729 2.286 . . . . 1.1799999999999999 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -155.68 156.34 26.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.689 -1.364 . . . . 1.0700000000000001 109.689 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 639' ' ' ALA . . . . . 0.87 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -100.78 135.05 42.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 0.85999999999999999 109.404 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 640' ' ' THR . . . . . 1.107 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.4 OUTLIER -94.39 148.66 22.0 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.955 0.884 . . . . 0.78000000000000003 110.789 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 641' ' ' CYS . . . . . 0.62 ' SG ' HG11 ' C' ' 562' ' ' VAL . 1.4 m -160.38 69.62 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 2.04 109.479 178.981 -93.155 -145.559 77.949 103.94 2.024 104.745 -107.896 119.351 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 642' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' C' ' 559' ' ' SER . . . -123.91 169.48 11.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.875 . . . . 3.6699999999999999 109.568 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 643' ' ' THR . . . . . 0.702 HG23 ' OG ' ' C' ' 559' ' ' SER . 43.1 p -116.63 105.42 12.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 4.79 109.451 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.021 -1.433 . . . . 7.4000000000000004 109.535 179.933 . . . . . . . . 0 0 . 1 stop_ save_